Skip to main content
KALV logo

KALV

KalVista Pharmaceuticals, Inc.

$0.00

0.00%

Trade Ideas Performance

Latest Closed Trade Idea

$0.00

0.00%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

0

Social

0

About

Events of KalVista Pharmaceuticals, Inc. (KALV)

KalVista Pharmaceuticals' stock has been impacted by several events over the past six months. Chiesi Group announced an acquisition offer for $27.00 per share, leading to analyst downgrades and a 52-week high for KalVista's stock. The company presented at the Needham Virtual Healthcare Conference and reported inducement grants. Insider selling occurred to cover RSU tax obligations. Positive interim Phase 3 data was announced for the KONFIDENT-KID trial. KalVista reported strong EKTERLY launch and Q4/Full Year 2025 revenue, as well as Q3 2025 earnings per share exceeding expectations.

Read more

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
KalVista Pharmaceuticals, Inc. (KALV) Live Stock Price, Chart & Financial News | Edge Hound